{"title":"随着时间的推移，ADHD药物的疗效减弱反映了更广泛的治疗人群","authors":"","doi":"10.1002/pu.31356","DOIUrl":null,"url":null,"abstract":"<p>A cohort study using Swedish national data has found that while use of medication treatments for attention-deficit hyperactivity disorder (ADHD) consistently reduced risk of self-harm, unintentional injury, and other adverse outcomes, these associations weakened in later years of the study. Investigators theorized that higher prescribing rates over time incorporated more individuals with less severe symptoms. Study results were published online June 25, 2025, in <i>JAMA Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 10","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Weakened benefits of ADHD drugs over time reflect broader treated population\",\"authors\":\"\",\"doi\":\"10.1002/pu.31356\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A cohort study using Swedish national data has found that while use of medication treatments for attention-deficit hyperactivity disorder (ADHD) consistently reduced risk of self-harm, unintentional injury, and other adverse outcomes, these associations weakened in later years of the study. Investigators theorized that higher prescribing rates over time incorporated more individuals with less severe symptoms. Study results were published online June 25, 2025, in <i>JAMA Psychiatry</i>.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"36 10\",\"pages\":\"1-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31356\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31356","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Weakened benefits of ADHD drugs over time reflect broader treated population
A cohort study using Swedish national data has found that while use of medication treatments for attention-deficit hyperactivity disorder (ADHD) consistently reduced risk of self-harm, unintentional injury, and other adverse outcomes, these associations weakened in later years of the study. Investigators theorized that higher prescribing rates over time incorporated more individuals with less severe symptoms. Study results were published online June 25, 2025, in JAMA Psychiatry.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
